⏳ Fetching live dividend data...
Home › Calculator › POAI Dividend Calculator 2026
Predictive Oncology Inc. · NASDAQ
Price: $4.91 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in POAI → $277766592.75M in 10 years · $23,091,854,244,243.68/month
Predictive Oncology Inc. (POAI), an organization driven by expertise and data, is dedicated to pioneering individualized cancer treatments through the application of artificial intelligence, primarily within the United States. The company conducts its operations across four distinct divisions: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics division offers extensive clinical diagnostic services, including tumor drug response assessments and genomic profiling, alongside contract research focused on patient-centered drug discovery. This latter service leverages active learning technology for foundational discovery, clinical and translational research, clinical trials, and the development and validation of diagnostics. Meanwhile, the zPREDICTA division excels in crafting organ-specific disease models, providing three-dimensional reconstructions of human tissues that accurately mirror various disease states and simulate drug responses, particularly for evaluating anticancer agents. The Soluble segment delivers services centered on High-Throughput Self-Interaction Chromatography, an automated system proficient at screening additives and excipients in protein formulations to ensure the creation of soluble and physically stable biologic therapeutics. This segment also provides protein stability analysis, specialized kits for swift identification of soluble formulations, and proprietary technologies for the detection and elimination of bacterial endotoxins. The Skyline division markets the STREAMWAY System, a fully automated, wall-mounted device designed to substantially minimize healthcare staff's exposure to blood and other infectious fluids in clinical environments. Furthermore, this division conducts research and development and supplies specialized media that supports the ex-vivo growth of cancer cells while maintaining their original DNA/RNA and proteomic signatures. Founded in 2002, the company was formerly known as Precision Therapeutics Inc. until it adopted the name Predictive Oncology Inc. in June 2019. Its corporate headquarters are situated in Eagan, Minnesota.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open POAI position with:
Real after-tax yield depends on where you live and how you hold POAI.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 40.73% | 37.93% | $4,073 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 34.62% | 31.82% | $3,462 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 32.58% | 29.78% | $3,258 / yr |
| 🇬🇧 UK ISA | 0% | 40.73% | 37.93% | $4,073 / yr |
| 🇬🇧 UK Taxable | 8.75% | 37.17% | 34.37% | $3,717 / yr |
| 🇨🇦 TFSA | 0% | 40.73% | 37.93% | $4,073 / yr |
| 🇨🇦 CA Taxable | 25% | 30.55% | 27.75% | $3,055 / yr |
| 🇦🇺 Super (pension) | 15% | 34.62% | 31.82% | $3,462 / yr |
| 🇦🇺 AU Taxable | 30% | 28.51% | 25.71% | $2,851 / yr |
| 🇩🇪 DE Taxable | 26.375% | 29.99% | 27.19% | $2,999 / yr |
| 🇫🇷 FR Taxable | 30% | 28.51% | 25.71% | $2,851 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
POAI pays quarterly — 4 times per year. Next ex-div: TBD.
How POAI compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for POAI sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-05-14 | 9,389 | — | — | ||
| F-InKind | 2025-11-28 | 2,373 | $5.90 | $14.0K | ||
| A-Award | 2025-09-09 | 64,680 | — | — | ||
| A-Award | 2025-09-09 | 64,680 | — | — | ||
| A-Award | 2025-09-09 | 64,680 | — | — | ||
| A-Award | 2025-09-09 | 64,680 | — | — | ||
| A-Award | 2025-09-09 | 64,680 | — | — | ||
| A-Award | 2025-09-09 | 64,680 | — | — | ||
| A-Award | 2025-09-09 | 97,000 | — | — | ||
| A-Award | 2025-09-09 | 124,959 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the POAI dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Predictive Oncology Inc. (POAI) is currently trading at $4.91, 99% below its 52-week high. The current dividend yield is 40.73% based on an annual payout of $2.00 per share.
Predictive Oncology Inc. (POAI) is a healthcare stock currently trading at $4.91 with a dividend yield of 40.73%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever